Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | Pexmetinib |
Synonyms | |
Therapy Description |
Pexmetinib (ARRY-614) inhibits Tie2, p38, and the BCR-ABL1 fusion, potentially leading to decreased cell proliferation and inhibition of tumor growth (PMID: 27287719, PMID: 25480830, PMID: 38750137). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
Pexmetinib | ARRY-614 | BCR-ABL Inhibitor 32 | Pexmetinib (ARRY-614) inhibits Tie2, p38, and the BCR-ABL1 fusion, potentially leading to decreased cell proliferation and inhibition of tumor growth (PMID: 27287719, PMID: 25480830, PMID: 38750137). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|